Rosalind A. Eeles spends much of her time researching Prostate cancer, Cancer, Genetics, Internal medicine and Oncology. Her Prostate cancer research includes themes of Genome-wide association study, Metastasis, Genotype and Prostate. Rosalind A. Eeles has researched Genome-wide association study in several fields, including Allele, Case-control study, Genetic association and Linkage disequilibrium.
Her biological study spans a wide range of topics, including Cancer research, Malignancy, Bioinformatics, Immunology and Disease. Her Internal medicine study combines topics from a wide range of disciplines, such as Germline mutation and Gynecology. Her Oncology study also includes
Her scientific interests lie mostly in Prostate cancer, Internal medicine, Oncology, Cancer and Breast cancer. The various areas that she examines in her Prostate cancer study include Genome-wide association study, Genotype, Single-nucleotide polymorphism, Prostate and Case-control study. She focuses mostly in the field of Internal medicine, narrowing it down to matters related to Gynecology and, in some cases, Family history and Risk factor.
Her research integrates issues of Genetic predisposition, Relative risk, Pathology, Proportional hazards model and Hazard ratio in her study of Oncology. The Cancer study which covers Cancer research that intersects with BRCA2 Protein and Tumor suppressor gene. Her work in Breast cancer tackles topics such as Genetic testing which are related to areas like Genetic counseling.
Her primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Genome-wide association study and Cancer. Her studies in Prostate cancer integrate themes in fields like Prostate, Proportional hazards model, Disease, Hazard ratio and Single-nucleotide polymorphism. Her Internal medicine research includes themes of Germline mutation and Gynecology.
Her Oncology research includes elements of Odds ratio, Genetic predisposition, Relative risk, Prostate-specific antigen and Family history. Genome-wide association study is a primary field of her research addressed under Genetics. Her work carried out in the field of Cancer brings together such families of science as Young adult, Lung cancer and Mass screening.
Her scientific interests lie mostly in Prostate cancer, Internal medicine, Genome-wide association study, Oncology and Cancer. Her biological study spans a wide range of topics, including BRCA2 Protein, Cancer research, Prostate, Disease and DNA repair. Her research ties Germline mutation and Internal medicine together.
Her Genome-wide association study study combines topics in areas such as Odds ratio, Case-control study and Genetic association. Her Oncology research is multidisciplinary, incorporating elements of Prostate-specific antigen, Breast cancer, Prospective cohort study and Hazard ratio. The study incorporates disciplines such as Mendelian randomization, Epidemiology, Young adult, Mass screening and Gynecology in addition to Cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo;Suzanne Carreira;Shahneen Sandhu;Susana Miranda.
The New England Journal of Medicine (2015)
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations
Hanne Meijers-Heijboer;Ans van den Ouweland;Jan Klijn;Marijke Wasielewski.
Nature Genetics (2002)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek;Tara M. Friebel;Christian F. Singer;D. Gareth Evans.
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach;C R M Boggis;A K Dixon;D F Easton.
The Lancet (2005)
Analysis of the p16 gene (CDKN2) as a candidate· for the chromosome 9p melanoma susceptibility locus
A. Kamb;D. Shattuck-Eidens;R. Eeles;R. Eeles;Qingyun Liu.
Nature Genetics (1994)
The evolutionary history of lethal metastatic prostate cancer.
Gunes Gundem;Peter Van Loo;Peter Van Loo;Peter Van Loo;Barbara Kremeyer;Ludmil B. Alexandrov.
Multiple newly identified loci associated with prostate cancer susceptibility.
Rosalind A Eeles;Rosalind A Eeles;Zsofia Kote-Jarai;Graham G Giles;Graham G Giles;Ali Amin Al Olama.
Nature Genetics (2008)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Colin C. Pritchard;Joaquin Mateo;Michael F. Walsh;Navonil De Sarkar.
The New England Journal of Medicine (2016)
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Nasim Mavaddat;Susan Peock;Debra Frost;Steve Ellis.
Journal of the National Cancer Institute (2013)
Localization of the gene for Cowden disease to chromosome 10q22-23
M. R. Nelen;G. W. Padberg;E. A J Peeters;A. Y. Lin.
Nature Genetics (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: